Related references
Note: Only part of the references are listed.Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells
J. Joseph Melenhorst et al.
NATURE (2022)
GD2-CART cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G. Majzner et al.
NATURE (2022)
Deciphering the immunopeptidome in vivo reveals new tumour antigens
Alex M. Jaeger et al.
NATURE (2022)
Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia
Han Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Cytokine Release Syndrome After Modified CAR-NK Therapy in an Advanced Non-small Cell Lung Cancer Patient: A Case Report
Xiaodi Zhang et al.
CELL TRANSPLANTATION (2022)
In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy
Yue Yin et al.
NANO LETTERS (2021)
Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology
Keman Cheng et al.
NATURE COMMUNICATIONS (2021)
Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19
Yue Yin et al.
ACS NANO (2021)
Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines
Long Chen et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala et al.
NATURE REVIEWS CANCER (2021)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
Chloe Chong et al.
NATURE COMMUNICATIONS (2020)
Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
Shuang Qing et al.
ADVANCED MATERIALS (2020)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
Daniel Shae et al.
NATURE NANOTECHNOLOGY (2019)
Engineering universal cells that evade immune detection
Robert Lanza et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Adoptive T cell cancer therapy
Karine N. Dzhandzhugazyan et al.
NATURE MATERIALS (2018)
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2017)
Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy
Kristin L. Griffiths et al.
NATURE COMMUNICATIONS (2016)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
Whole Tumor Antigen Vaccines: Where Are We?
Cheryl Lai-Lai Chiang et al.
VACCINES (2015)
Multiconfi gurable Logic Gates Based on Fluorescence Switching in Adaptive Coordination Polymer Nanoparticles
Fang Pu et al.
ADVANCED MATERIALS (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Structure-based programming of lymph-node targeting in molecular vaccines
Haipeng Liu et al.
NATURE (2014)
Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
Xiao-Dong Li et al.
SCIENCE (2013)
Nanoparticles of Adaptive Supramolecular Networks Self-Assembled from Nucleotides and Lanthanide Ions
Ryuhei Nishiyabu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Mechanisms and consequences of dendritic cell migration
David Alvarez et al.
IMMUNITY (2008)
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study
HS Pandha et al.
BJU INTERNATIONAL (2004)
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection
W Lu et al.
NATURE MEDICINE (2004)